Por un escritor de hombre misterioso
Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder. Part 1 was a great […]
<!-- wp:paragraph --> <p>Join us in a discussion as young adults and experienced members of the community share their knowledge with each other. This discussion is intended to “close the generation gap” and provide a space for community members, both younger and wiser, to share their perspectives and experiences with their bleeding disorder.</p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p>Part 1 was a great success, and we can't wait for you to join us for part 2. </p> <!-- /wp:paragraph -->
The Next Big Thing in Health Reform: Where to Start? - The American Prospect
History of Bleeding Disorders - Hemophilia Federation of America
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions – DrugPatentWatch - Make Better Decisions
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
CV 5 17 15
Housing Market: Biden Wants to Fix Eviction Crisis, Spiraling Home Prices - Bloomberg
Hemophilia Federation of America
Working with Rare Disease Communities and Advocacy Groups
News – WFH - World Federation of Hemophilia
What Is Hemophilia? Symptoms, Causes, Diagnosis, and Treatment
Managing Inhibitors in Hemophilia A: Treatment Strategies
Fitzsimons Innovation Community and Aimco Host Media Event Focused on Sharing Momentum, Trends, and Patient-Impact Storylines - Colorado Bioscience Association
Prophylaxis and hemophilia care in LATAM: Baring it all—Highlights from the CLAHT 2021 symposium - DiMinno - 2022 - eJHaem - Wiley Online Library